Get started
Work

Figure S2 from A Phase 1b Dose Escalation Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft-tissue Sarcoma

Year: 2023
Type: other
Abstract: Figure S2. shows mean Change in EORTC QLQ-C30 Score from Baseline.
DOI: 10.1158/1078-0432.22476188.v1
Authors: Sant P. Chawla, Sanjay Goel, Warren Chow, Fadi Braiteh, Arun S. Singh, Juneko E. Grilley Olson, Atsushi Osada, Iulian Bobe, Richard F. Riedel
Language: English
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361936930
Cites:
Cited by:
Related to: 10